US Patent 7993835 BRCA2 mutations and use thereof
Patent 7993835 was granted and assigned to Myriad Genetics on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+105 characters)
Article
Patent abstract
Genetic variants in the BRCA2 gene are disclosed which are useful as diagnosis biomarkers.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Amie Deffenbaugh0
Brian E. Ward0
Lynn Anne Burbidge0
Thomas M. Scholl0
Walter W. Noll0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07993835 BRCA2 mutations and use thereof US Patent 7993835 BRCA2 mutations and use thereof
Infobox
Patent Number
079938350
Patent Number
79938350
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079938350
Date of Patent
August 9, 2011
0Patent Application Number
121168530
Date Filed
May 7, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07993835 BRCA2 mutations and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07993835
Date of patent
August 9, 2011
Patent application number
12116853
Date Filed
May 7, 2008
Patent primary examiner
Find more entities like US Patent 7993835 BRCA2 mutations and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
